Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

Eleva is separating its moss-based biologics platform from its clinical-stage [...]

Fuse Diagnostics has raised £1 million to scale manufacturing and [...]

A systematic review of more than two decades of clinical [...]

Circio is preparing to advance its circular RNA gene therapy [...]

HAYA Therapeutics has received FDA Fast Track designation for HTX-001, [...]

Mission Therapeutics has signed a deal worth up to US$292 [...]

Latent Labs has launched its artificial intelligence-powered drug design platform [...]

Vect-Horus has entered a research collaboration and exclusive licence option [...]

Lonza has acquired the rights to Nona Biosciences’ transferrin receptor [...]